 | Supernus Pharmaceuticals, Inc. | |||
| NGM : SUPN || Location: United States | ||||
$30.12+0.81 (+2.76%) |
0.21 M | 29.18 - 30.17 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 4.681 M |
| March 28, 2024 | 4.823 M |
| March 15, 2024 | 4.924 M |
| Feb. 29, 2024 | 4.408 M |
| Feb. 15, 2024 | 4.032 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | 0.56 | 0.89 | 57.69% |
| 09/30/2023 | 0.08 | 0.24 | 194.12% |
| 06/30/2023 | 0.07 | -0.02 | -130.17% |
| 03/31/2023 | 0.17 | 0.29 | 67.24% |
| 12/31/2022 | 0.69 | 0.43 | -38.00% |
SUPN Basic Data
| Sector | Healthcare | Industry | Drug Manufacturers - Specialty & Generic |
| Shares Outstanding | 54.735M | Shares Float | 47.706M |
| Short Float | 4.681M | Market Cap | 1604.28M |
| Institution ownership | 0.00% | Insider ownership | 5.116% |
| Earnings Date | 05/07/2024 AMC | Cash Per Share | ? |
| Trailing EPS | 0.02 | Forward EPS | 1.95 |